VVUS on NASDAQ

Vivus

Logo: vivus.com⁵

Pharmaceutical Company

Price unavailable

Last updated Oct 19, 2026.

Overview

1991Founded¹

Compare with another stock.

TickerVVUS on NASDAQ¹
Industrypharmaceutical industry¹
HeadquartersMountain View¹
Websitewww.vivus.com
Legal formDelaware corporation¹
Incorporated inDE⁶
Business address900 E. Hamilton Avenue, Suite 550, Campbell, Ca 95008⁶
Filer categoryNon-accelerated filer, Smaller reporting company⁶
LEI549300PC33SFMFILV612⁴
StatusActive⁴
LEI statusLapsed (not renewed)⁴
Registered addressC/O The Corporation Trust Company, 19801 Wilmington, United States⁴
Registered withDivision of Corporations, Department of State, 2624559⁴

See how the biggest companies compare on our leaderboards

Vivus (OTCID Basic: VVUSQ) is a small pharmaceutical company headquartered in Campbell, California that specializes in obesity, sleep, and sexual health. Vivus developed Avanafil, an erectile dysfunction drug that has completed Phase 3 clinical trials. The drug has been approved for use by the Food and Drug Administration, and is sold under the trademark name Stendra. Stendra is the first and only oral erectile dysfunction treatment approved to be taken approximately 15 minutes before sexual activity.³

Leadership

Who has led Vivus, and when. Pick a name to see everywhere that person has worked.

Chief executive

Chair

Virgil A. Place2006–2007

President

Chief financial officer

Chief operating officer

Peter Y. Tam2009

1995200020052010201520202025

Chief executive officerThomas Braxton King Jan 30, 2018 to Jan 30, 2018⁷
Chief executive officerJohn P. Amos May 2, 2018 to Jan 31, 2020⁸
Chief executive officerAnthony P. Zook Jul 29, 2013 to Jul 29, 2013⁹
Chief executive officerLeland F. Wilson Jan 31, 2006 to Jan 29, 2013¹⁰
ChairVirgil A. Place Jan 31, 2006 to Aug 30, 2007¹¹
PresidentKenneth Suh Aug 9, 2018 to Jan 25, 2019¹²
PresidentPeter Y. Tam Nov 3, 2009 to Jan 29, 2013¹³
PresidentLeland F. Wilson Jan 31, 2006 to Sep 11, 2009¹⁰
Chief financial officerJohann Noor Mohamed Oct 5, 2015 to Oct 5, 2015¹⁴
Chief financial officerMark K. Oki Oct 20, 2015 to Jan 31, 2020¹⁵
Chief financial officerSvai S. Sanford Nov 8, 2013 to Aug 5, 2015¹⁶
Chief financial officerTimothy E. Morris Jan 31, 2006 to Sep 9, 2013¹⁷
Chief operating officerPeter Y. Tam Jan 27, 2009 to Jan 27, 2009¹⁸

Board members and other officers (39)

Chief Operations OfficerM. Scott Oehrlein May 2, 2018 to Jan 25, 2019¹⁹
SVP, Business Dev., GCJohn L. Slebir Jan 27, 2015 to Jan 31, 2020²⁰
VP, Medical & Reg AffairsSantosh T. Varghese Apr 29, 2015 to Jan 31, 2020²¹
Chief Commercial OfficerMichael /ny/ Miller Jan 31, 2012 to Jan 31, 2012²²
VP, Operations & General Mgr.Guy P. Marsh Jan 29, 2008 to Apr 20, 2016²³
Vice President & ChiefLee Perry Feb 28, 2007 to Jan 29, 2013²⁴
Chief Scientific OfficerVirgil A. Place Sep 4, 2007 to May 7, 2010²⁵
Senior VP, Product &Peter Y. Tam Jan 31, 2006 to Dec 3, 2008²⁶
VP, Worldwide Marketing/Terry Nida Jan 31, 2006 to Jan 3, 2007²⁷
VP, Clinical ResearchWesley Day Jan 31, 2006 to Apr 20, 2016²⁸
SecretaryMario M. Rosati Jun 15, 2006 to Jan 29, 2008²⁹
VP, Business DevelopmentWang Changjin Nov 2, 2006 to Dec 1, 2008³⁰
Board memberJohn P. Amos May 2, 2018 to Jan 31, 2020⁸
Board memberEdward A. Kangas Oct 29, 2018 to Feb 24, 2020³¹
Board memberKaren E. Ferrell Oct 29, 2018 to Feb 24, 2020³²
Board memberConan Laughlin Feb 8, 2017 to Mar 10, 2017³³
Board memberThomas Braxton King May 24, 2017 to Feb 24, 2020³⁴
Board memberAllan Shaw Sep 24, 2015 to Oct 29, 2018³⁵
Board memberMayu Sris Sep 24, 2015 to Dec 19, 2016³⁶
Board memberRobert N. Wilson Apr 30, 2013 to Aug 16, 2013³⁷
Board memberJ. Martin Carroll May 13, 2013 to Aug 16, 2013³⁸
Board memberJorge Plutzky Md. May 13, 2013 to Feb 24, 2020³⁹
Board memberAnthony P. Zook Jul 29, 2013 to Jul 29, 2013⁹
Board memberDavid Y. Norton Jul 29, 2013 to Feb 24, 2020⁴⁰
Board memberHerm Rosenman Jul 29, 2013 to Feb 24, 2020⁴¹
Board memberJacob Pieter Kastelein Johannes Jul 29, 2013 to Aug 16, 2013⁴²
Board memberMichael J. Astrue Jul 29, 2013 to Sep 6, 2013⁴³
Board memberSamuel F. Colin Jul 29, 2013 to May 1, 2014⁴⁴
Board memberAlexander J. Denner Aug 16, 2013 to Nov 3, 2015⁴⁵
Board memberErnest Mario Apr 27, 2012 to May 30, 2013⁴⁶
Board memberPeter Y. Tam Nov 3, 2009 to Jan 29, 2013¹³
Board memberCharles J. Casamento Apr 21, 2008 to Apr 22, 2013⁴⁷
Board memberVirgil A. Place Sep 4, 2007 to May 7, 2010²⁵
Board memberGraham Strachan Jan 31, 2006 to May 7, 2010⁴⁸
Board memberLeland F. Wilson Jan 31, 2006 to Jan 29, 2013¹⁰
Board memberLinda M. Dairiki Shortliffe Jan 31, 2006 to Jan 29, 2013⁴⁹
Board memberMario M. Rosati Jan 31, 2006 to Sep 9, 2008⁵⁰
Board memberMark B. Logan Jan 31, 2006 to Aug 16, 2013⁵¹
General counselJohn L. Slebir Nov 4, 2009 to Jul 7, 2014⁵²

Timeline

May 2, 2018New chief executive John P. Amos becomes CEO⁸
Jan 30, 2018New chief executive Thomas Braxton King becomes CEO⁷
Jul 29, 2013New chief executive Anthony P. Zook becomes CEO⁹
Jan 31, 2006New chief executive Leland F. Wilson becomes CEO¹⁰
1991Founded Founded¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataVivus on Wikidata
2
SEC EDGARVivus filings on SEC EDGAR
3
WikipediaVivus on Wikipedia
4
GLEIFVivus LEI record (549300PC33SFMFILV612)
5
Company websiteVivus logo
6
SEC EDGARVivus filings on SEC EDGAR
7
SEC EDGARThomas Braxton King, Chief executive officer
8
SEC EDGARJohn P. Amos, Chief executive officer
9
SEC EDGARAnthony P. Zook, Chief executive officer
10
SEC EDGARLeland F. Wilson, Chief executive officer
11
SEC EDGARVirgil A. Place, Chair
12
SEC EDGARKenneth Suh, President
13
SEC EDGARPeter Y. Tam, President
14
SEC EDGARJohann Noor Mohamed, Chief financial officer
15
SEC EDGARMark K. Oki, Chief financial officer
16
SEC EDGARSvai S. Sanford, Chief financial officer
17
SEC EDGARTimothy E. Morris, Chief financial officer
18
SEC EDGARPeter Y. Tam, Chief operating officer
19
SEC EDGARM. Scott Oehrlein, Chief Operations Officer
20
SEC EDGARJohn L. Slebir, SVP, Business Dev., GC
21
SEC EDGARSantosh T. Varghese, VP, Medical & Reg Affairs
22
SEC EDGARMichael /ny/ Miller, Chief Commercial Officer
23
SEC EDGARGuy P. Marsh, VP, Operations & General Mgr.
24
SEC EDGARLee Perry, Vice President & Chief
25
SEC EDGARVirgil A. Place, Chief Scientific Officer
26
SEC EDGARPeter Y. Tam, Senior VP, Product &
27
SEC EDGARTerry Nida, VP, Worldwide Marketing/
28
SEC EDGARWesley Day, VP, Clinical Research
29
SEC EDGARMario M. Rosati, Secretary
30
SEC EDGARWang Changjin, VP, Business Development
31
SEC EDGAREdward A. Kangas, Board member
32
SEC EDGARKaren E. Ferrell, Board member
33
SEC EDGARConan Laughlin, Board member
34
SEC EDGARThomas Braxton King, Board member
35
SEC EDGARAllan Shaw, Board member
36
SEC EDGARMayu Sris, Board member
37
SEC EDGARRobert N. Wilson, Board member
38
SEC EDGARJ. Martin Carroll, Board member
39
SEC EDGARJorge Plutzky Md., Board member
40
SEC EDGARDavid Y. Norton, Board member
41
SEC EDGARHerm Rosenman, Board member
42
SEC EDGARJacob Pieter Kastelein Johannes, Board member
43
SEC EDGARMichael J. Astrue, Board member
44
SEC EDGARSamuel F. Colin, Board member
45
SEC EDGARAlexander J. Denner, Board member
46
SEC EDGARErnest Mario, Board member
47
SEC EDGARCharles J. Casamento, Board member
48
SEC EDGARGraham Strachan, Board member
49
SEC EDGARLinda M. Dairiki Shortliffe, Board member
50
SEC EDGARMario M. Rosati, Board member
51
SEC EDGARMark B. Logan, Board member
52
SEC EDGARJohn L. Slebir, General counsel